Remimazolam

Byfavo 20 MG Polvo Para Solucion Inyectable

27,2 mg polvo para solución inyectableSpainAuthorisedAuthorised 31 Jul 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ByfavoEuropean UnionAuthorised

ByfavoBrazil · Cristália Produtos Químicos Farmacêuticos Ltda.Same brand
ByfavoEuropean Union · Paion Pharma GmbHSame brand
ByfavoCroatiaSame brand
ByfavoItaly · Polvere per concentrato per soluzione iniettabile/infusione · Paion Pharma GMBHSame brand
Byfavo 20 mg, poeder voor oplossing for injectie of infusieNetherlands · Poeder voor oplossing voor injectie of infusie · Paion Pharma GmbHSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Remimazolam

Byfavo 20 MG Polvo Para Solucion Inyectable

27,2 mg polvo para solución inyectableSpainAuthorisedAuthorised 31 Jul 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ByfavoEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Byfavo 50 mg, poeder voor concentraat voor oplossing voor injectie/infusie

Netherlands · Poeder voor concentraat voor oplossing voor injectie / infusie · Paion Pharma GmbH

Byfavo Powder for Solution for Injection 20MGSingapore · 20 mg · injection, powder, lyophilized, for solution · Hyphens Pharma Pte. LTD.

ByfavoUnited States · 20MG BASE/VIAL · powder · Acacia

Packs

Pack	Code	Status
BYFAVO 20 MG POLVO PARA SOLUCION INYECTABLE, 10 viales	763070

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Remimazolam
Strength: 27,2 mg
Dosage form: polvo para solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 31 Jul 2023
Registration: 1201505001
Marketing authorisation holder: Paion Pharma Gmbh
Procedure: EU centralised
Supply: Uso Hospitalario. Psicótropos
EU number: EU/1/20/1505